Latest Breaking News On - Mortality worldwide - Page 11 : comparemela.com

First participant treated at the highest dose level in Clarity s theranostic prostate cancer trial

First participant treated at the highest dose level in Clarity s theranostic prostate cancer trial
australiannews.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from australiannews.net Daily Mail and Mail on Sunday newspapers.

New south walesUnited statesAlan taylorPrnewswire clarity pharmaceuticalsTechnology platformDrug administrationAmerican cancer societyAmerican cancer instituteClarity pharmaceuticalsProstate specific antigenProstate specific membrane antigenExecutive chairpersonCancer statisticsMortality worldwideCancer societyKey statistics

Clarity reaches 50% recruitment milestone for Phase II SABRE prostate cancer trial

/PRNewswire/ Clarity Pharmaceuticals (ASX: CU6) ("Clarity", "the Company"), a clinical stage radiopharmaceutical company with a mission to develop.

United statesNew south walesGuggerm bombesinAndrei iagaruAlan taylorPrnewswire clarity pharmaceuticalsAmerican cancer instituteAmerican cancer societyClarity pharmaceuticalsBiochemical recurrenceEmission tomographyLead principal investigatorExecutive chairmanTargeted copper theranosticClin cancerCancer statistics

Clarity reaches 50% recruitment milestone for Phase II SABRE prostate cancer trial

Clarity reaches 50% recruitment milestone for Phase II SABRE prostate cancer trial
kualalumpurtimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kualalumpurtimes.com Daily Mail and Mail on Sunday newspapers.

United statesNew south walesAndrei iagaruGuggerm bombesinAlan taylorPrnewswire clarity pharmaceuticalsAmerican cancer societyClarity pharmaceuticalsAmerican cancer instituteBiochemical recurrenceEmission tomographyLead principal investigatorExecutive chairmanTargeted copper theranosticClin cancerCancer statistics

Clarity reaches 50% recruitment milestone for Phase II SABRE prostate cancer trial

Clarity reaches 50% recruitment milestone for Phase II SABRE prostate cancer trial
sydneysun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sydneysun.com Daily Mail and Mail on Sunday newspapers.

United statesNew south walesAndrei iagaruAlan taylorGuggerm bombesinAmerican cancer institutePrnewswire clarity pharmaceuticalsClarity pharmaceuticalsAmerican cancer societyBiochemical recurrenceEmission tomographyLead principal investigatorExecutive chairmanTargeted copper theranosticClin cancerCancer statistics

ACCESS Consensus Group: Experts Warn of an Increase in Cervical Cancer if Under-screened Women Are Not Prioritised

Screening programmes remain the most powerful tool to reduce cervical cancer rates in the near term, but there is a concerning decline in participation in some.

Bruxelles capitaleUnited kingdomSamantha dixonPhilippe descampsResearch in europeConsensus group white paperInternational consensus group on cervical cancerInternational consensus groupConsensus groupWorld health organizationJo cervical cancerWhite paperAdvancing cervical cancer screeningsCervical cancerVice presidentChief executive officer